Business
4CAble TV International, Inc. Announces it has begun the process for its Name Change to Category V Biotech, Inc.
4CAble TV International, Inc. Announces it has begun the process for its Name Change to Category V Biotech, Inc..
About this update from 4cable Tv International, Inc.
[{"type":"text","content":"FOR IMMEDIATE RELEASE4Cable TV International, Inc Announces it has begun the process for its Name Change to Category V Biotech, Inc. Following Successful Resolution of Caveat Emptor Designation[Miami, FL 11/27/2023] – 4Cable TV International, Inc (OTC: CATV) is pleased to announce a pivotal moment in its corporate history as it commences the formal process of changing its name to Category V Biotech, Inc. This strategic decision comes on the heels of the successful removal of the Caveat Emptor designation that the company has diligently navigated for the past two-plus years. Please note that the name change process requires approval from the State of Florida Division of Corporations and FINRA, and we appreciate your patience during this period.The recently removed Caveat Emptor designation that had applied to our common shares, akin to a financial storm, had been our Category V “Hurricane”. We commend our shareholders for their unwavering support and patience during this challenging period relating to the pendency of that designation. This name change signifies a new chapter for our company as we transition to Category V Biotech, Inc, reflecting our commitment to innovation, growth, and resilience. Through the diligence of our team and the support of our shareholders, we have successfully weathered this storm, emerging stronger and more resolute than ever.Following the successful outcome of the Caveat Emptor designation and the rebranding to Category V Biotech, Inc, our company is eager to share its strategic vision for the future. Category V Biotech, Inc aims to revolutionize our industry with a comprehensive and science-driven approach.New Vision: Category V Biotech, Inc represents not merely a name change but a strategic shift with a renewed focus on creating Category V-type products both nationally and internationally, harnessing the power of science. Our objective is to leverage scientific innovation to develop groundbreaking products with a significant impact on a national scale. This evolution aligns with our commitment to pioneering advancements in biotechnology that reshape industries and enhance lives.Foundational Approach: To ensure the production and quality of our products remain at their pinnacle, we will adopt a deliberate and measured approach, commencing with a small-scal...